AI-Powered News AnalysisCompare coverage across the political spectrum
Back to Dashboard
Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters

Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters

Psychedelic drug developers rally as Trump orders FDA to expedite reviews Reuters

April 20, 2026 at 02:44 PM Original source
5 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
2 articles
Center
2 articles
Lean Right
0 articles
No coverage
Right
1 articles

Key People

No people linked to this story

All Coverage

Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPRkt5UW9leHZFZmU0NUdRWWNIR3YtM19sNlZQRXduUFFmZWs2NXVXaGdYOTVTelNWQzRkbWU0cHhPU0hFYmw3VlN4VkhnTTJYMUVtZW95U1JvNHk4dUVfWjQ1X0s4XzRwV1JMS2dGZVFFcjZTYXhaelJhZGQ3RkZOLWNqSzdKMFJHcmFSZkNjTTFaVW9hWVZJMkZGM1lUVkxXQWRSRk1DYUU3LWZCdjFtcUh0dTVMM2lYUzE2SzVaSktFaTNtWExJX2cxODc0ZUFp?oc=5" target="_blank">Psychedelic drug developers rally as Trump orders FDA to expedite reviews</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%
Psychedelic drug developers rally as Trump orders FDA to expedite reviews
Reutersvia ai

Shares of psychedelic drug developers rose after President Trump signed an executive order directing the FDA to fast-track reviews of psychedelic drugs and increase federal research funding.

80%
Trump signs executive order accelerating research into psychedelic drug therapies
ABC Newsvia ai

President Trump signed an executive order to accelerate research and approval of psychedelic-based therapies, particularly ibogaine, for conditions like PTSD, depression, and addiction.

80%
Newsmaxvia ai

Shares of psychedelic drug developers rose after President Trump signed an executive order directing the FDA to fast-track reviews of psychedelic drugs and boost federal research funding.

80%
Trump signs order to accelerate access to psychedelic drug treatments
The Jakarta Postvia ai

President Trump signed an executive order to speed up access to medical research and treatment based on psychedelic drugs, instructing the FDA to expedite the review of drugs like ibogaine.

80%